Christian Behrenbruch
MD & Group CEO at Telix Pharmaceuticals Limited
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 6 months
- Director since
- 2026
6 months of board service in total across 1 board, counting each seat separately. Longest: Telix Pharmaceuticals Limited, 6 months.
Telix Pharmaceuticals Limited
Director · MD & Group CEO
Chief executive roles
Telix Pharmaceuticals Limited
· MD & Group CEO
Since March 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 29, 2026 | Telix Pharmaceuticals Limited | Open-market purchase | +33,435 | $14.87 | $497,178 |
| Apr 28, 2026 | Telix Pharmaceuticals Limited | Open-market purchase | +34,500 | $14.48 | $499,560 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.